Biden's Greenlight: What To Know About Fed-Regulated Marijuana, Markets, Legal Circuits And Compliance

Benzinga ·  May 17 04:41

In an exclusive interview with Benzinga Cannabis,Aaron Bloom, an attorney and CEO ofDocMJ, a multistate cannabis clinic, delved into the legal steps for rescheduling cannabis to Schedule III in the Controlled Substances Act, the possibility of categorizing cannabis under different regulatory frameworks, and how these changes may bring both challenges and opportunities for informed investors.

"Many practices that are common in the cannabis industry today, will become illegal under a federally regulated cannabis framework," Bloom explained.

Bureaucratic Road Map For Rescheduling Cannabis

The DEA's decision to reschedule cannabis from Schedule I to Schedule III marks a significant...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment